≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat
    ≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat

    Research use only · Not for human or veterinary use

    α
    ALPHA CARBON LABS
    Best Seller
    BPC-157 research peptide - high purity lyophilized powder for laboratory research
    3ml Vial

    5MG

    $45
    In Stock
    Bulk Discounts

    Buy 3+ for $42.75 each and save 5%

    Buy 5+ for $40.50 each and save 10%

    Buy 10+ for $38.25 each and save 15%

    This product is for research purposes only. Not for human consumption.

    Purity: ≥99% (HPLC verified)

    Formulation: Lyophilized powder

    Molecular Formula: C62H98N16O22

    Molecular Weight: 1419.5 g/mol

    CAS Number: 137525-51-0

    PubChem CID: 9941957

    BPC-157 Molecular Structure

    BPC-157

    Tissue Repair Research

    Overview

    This material is provided for controlled laboratory research and analytical characterization only.

    Mechanism of Action

    BPC-157 has also been reported to modulate the nitric oxide (NO) signaling pathway. In studies of wound healing models, it has been observed to affect fibroblast activity and the expression of growth factors such as fibroblast growth factor (FGF) and epidermal growth factor (EGF), which are associated with collagen deposition.

    Its effects on inflammatory processes have been attributed in some studies to the modulation of cytokine production, such as TNF-α and IL-6. Other reports describe effects on cellular membrane stability and responses to oxidative stress.

    In models of the gastrointestinal tract, BPC-157 has been observed to influence epithelial cell behavior and mucosal blood flow. In neuroscience research, it has been shown to interact with neurotransmitter systems, including dopaminergic and GABAergic pathways. Some research has also pointed to its ability to modulate the expression of genes involved in cellular migration and extracellular matrix remodeling.

    Research Findings

    Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

    Research Applications

    • Angiogenesis assays
    • Inflammation research
    • Wound healing models
    • Tendon injury models
    • Ligament injury models
    • Muscle injury models
    • Bone fracture models
    • Gastrointestinal research
    • Surgical anastomosis models
    • Cardiovascular research
    • Neuroscience research

    Laboratory Handling & Limitations

    This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

    Laboratory Handling

    Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

    Research Limitations

    Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.

    Scientific References

    1. Sikiric, P., et al. (2017). Stable gastric pentadecapeptide BPC 157-NO-system relation. Current Pharmaceutical Design, 23(35), 5309-5325.
    2. Chang, C. H., et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774-780.
    3. Sikiric, P., et al. (2014). Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications. Current Neuropharmacology, 14(8), 857-865.
    4. Kang, E. A., et al. (2018). BPC157 as potential agent rescuing from cancer cachexia. Current Pharmaceutical Design, 24(18), 1947-1956.
    5. Seiwerth, S., et al. (2014). BPC 157 and blood vessels. Current Pharmaceutical Design, 20(7), 1121-1125.

    Research Use Only

    This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.